The clinic on Rama 1 Road in Bangkok’s Pathum Wan district had a file on Igho Ubiribo going back to 2024. By the time Thai health inspectors walked through its doors on 7 September 2026, that file recorded five separate procedures on the same patient, the last of which preceded his death by a matter of hours.
Ubiribo, a 43 year old British Nigerian businessman and social media figure known variously as Tiny, Denisi and Ego, died in the early hours of 6 March 2026 while on holiday in Thailand with his wife, the fashion designer Danielle Simba Allen. What killed him has now been established twice over, by a coroner in London and by a postmortem examination in the United Kingdom. What remains under examination is how a cosmetic clinic came to inject 40 millilitres of hyaluronic acid and lidocaine into a patient’s penis in a single sitting, after its own doctor had reportedly advised splitting the dose.
That detail is the newest and arguably the most consequential fact to emerge. According to the account the clinic’s management gave to Thailand’s Department of Health Service Support, Ubiribo had been a regular patient since 2024 and had received four earlier injections between 2024 and 2025 before the fifth and final procedure on 5 March 2026. The clinic said its doctor recommended administering the last dose across two sessions, but that the patient preferred a single injection. It also said post operative instructions were given, follow up was carried out, no problems were reported by the patient, and consent forms were signed before each procedure. No finding of malpractice has been announced against the clinic, and its identity has not been released by either the Thai authorities or the London inquest.
The sequence that followed the injection is documented in unusual detail because it was reconstructed in two jurisdictions. Ubiribo, who was staying at the Marriott Marquis Queen’s Park hotel, went for a massage after the procedure. During it he complained of chest pain and lost consciousness twice. An ambulance was requested by a private hospital in the Sukhumvit area for a patient who had collapsed, and he was taken to Sukhumvit Hospital, where he was initially alert and able to answer questions. His wife told medical staff he had received filler injections that same day. Doctors suspected a pulmonary embolism, a clot or foreign material blocking blood flow in the lungs, and prepared a contrast enhanced computed tomography angiography to image the blood vessels in three dimensions. He lost consciousness before the scan could be performed. Medical staff attempted cardiopulmonary resuscitation for more than 100 minutes without response.
At the inquest held at Inner West London Coroners’ Court, Dr Thongchai Chansirirattingkul of Sukhumvit Hospital gave evidence on the collapse and the 40 millilitre dose administered earlier that day. A postmortem examination in the United Kingdom found material in the lungs consistent with the hyaluronic acid used in the penile filler procedure. Coroner Jean Harkin concluded that Ubiribo died as the result of a cosmetic procedure abroad, recording the cause of death as pulmonary embolism resulting from the injection of hyaluronic acid into the penis.
The Thai investigation was ordered after that conclusion became public. Public Health Minister Pattana Promphat directed the Department of Health Service Support and the Food and Drug Administration to examine the clinic and its operations. Officials from both agencies inspected the facility, collected evidence and are examining whether it holds a valid licence and observed health and safety protocols. Bangkok police are running a parallel inquiry, according to senior police official Utit Soodjai. Phuwadej Surakhot, Director General of the DHSS, said the agency would gather all facts and evidence to act within its authority and would submit the professional practice question to Thailand’s Medical Council for a ruling, in order to ensure fairness to all parties.
Placing the case in medical context requires care, because the clinical literature on penile girth augmentation with hyaluronic acid is not uniformly negative. A retrospective review of 471 men treated with a hyaluronic acid dermal filler, presented to the Sexual Medicine Society of North America, recorded only minor complications, including two injection site infections and three granulomas, all resolved. Published case reports and review articles describe hyaluronic acid as the most commonly used penile filler and generally associated with lower complication rates than silicone, polymethylmethacrylate or self injected non medical materials, provided standardised low volume protocols are followed. Documented problems tend to be local rather than systemic: migration, nodules, swelling, infection, phimosis. Fatal pulmonary embolism does not appear in these series as a routine risk. Notably, dermal fillers have not been approved by the United States Food and Drug Administration for penile augmentation, and one published case observation of the technique involved image guided placement between the dartos and Buck fascia, producing a girth increase from 12.3 to 13.0 centimetres. Against that literature, a 40 millilitre single session dose stands out, and the interval of hours between injection and collapse is what the two investigations are effectively testing.
The wider setting is Thailand’s position as one of the world’s leading destinations for medical and cosmetic travel. Figures cited by the Tourism Authority of Thailand put the country’s health tourism revenue target at around 125 billion baht for 2026, drawn from roughly 580,000 medical tourists in 2025, about 1.7 per cent of total international arrivals. Thailand holds more than 60 hospitals accredited by Joint Commission International, the most in Southeast Asia, and cosmetic surgery ranks among its top specialities alongside dentistry and orthopaedics. That accredited hospital tier, however, sits alongside a far larger and more loosely monitored population of standalone clinics, which is the segment now under scrutiny.
For Nigerian and diaspora readers, the case carries a practical rather than moral lesson. Ubiribo, who had roughly 185,000 Instagram followers and was buried in London in May, was a repeat patient at a clinic he apparently trusted, and he signed consent each time. The question the Medical Council in Bangkok will now weigh is whether consent, in a procedure with no approved regulatory pathway, can substitute for a clinical judgment the treating doctor is said to have made and then set aside.